Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Marco Boeri"'
Autor:
Michael J. Doane, Marco Boeri, Caroline Vass, Cooper Bussberg, Hemangi R. Panchmatia, Leslie Citrome, Martha Sajatovic
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Antipsychotic medications are effective treatments for schizophrenia (SZ) and bipolar I disorder (BD-I), but when presented with different treatment options, there are tradeoffs that individuals make between clinical improvement a
Externí odkaz:
https://doaj.org/article/1d30bcbf643843d0b57bde84a0457bb8
Autor:
Carol Mansfield, Marco Boeri, Josh Coulter, Eileen Baranowski, Susan Sparks, Kristina An Haack, Alaa Hamed
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-11 (2024)
Abstract Background Genetic testing can offer early diagnosis and subsequent treatment of rare neuromuscular diseases. Options for these tests could be improved by understanding the preferences of patients for the features of different genetic tests,
Externí odkaz:
https://doaj.org/article/4f87b512d9d74070b33b0313593413c4
Autor:
Steven R. Feldman, Jacob P. Thyssen, Marco Boeri, Robert Gerber, Maureen P. Neary, Amy Cha, Brett Hauber, Joseph C. Cappelleri, Jason Xenakis, Colton Leach, Joshua Zeichner
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
AbstractPurpose: Topical treatments for mild-to-moderate (MM) atopic dermatitis (AD) include emollients, corticosteroids, calcineurin inhibitors, a Janus kinase inhibitor, and a phosphodiesterase 4 inhibitor, which differ in multiple ways. This study
Externí odkaz:
https://doaj.org/article/381c24a10916409ba5aff352aa5817bc
Autor:
Paula Sinead Donnelly, Aoife Sweeney, Emily Wilson, Anthony Peter Passmore, Noleen K. McCorry, Marco Boeri, Joseph P. M. Kane
Publikováno v:
Frontiers in Dementia, Vol 3 (2024)
IntroductionThe development of high-quality stated preference (SP) surveys requires a rigorous design process involving engagement with representatives from the target population. However, while transparency in the reporting of the development of SP
Externí odkaz:
https://doaj.org/article/41f324fbe2d74df09bfee9b26ea916b4
Autor:
Othman AlHarbi, Niazy Abu Farsakh, Sameer Al-Awadhi, Talal Al-Taweel, Inas Mikhail, Faisal Batwa, Khalil Bedran, Dilara Balkan, Levent Mert Gunay, Joseph C. Cappelleri, Marco Boeri, Colton Leach, Sara Habjoka, Mahmoud Mosli
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 2, Pp 190-200 (2024)
Background and Aims: Treatments for ulcerative colitis (UC) differ in safety, efficacy, and route of administration; patient preferences for treatment attributes should be considered in treatment decisions. No study to date has explored patient prefe
Externí odkaz:
https://doaj.org/article/caffa4965ef9401f9423f7161986b562
Autor:
Flora McErlane, Marco Boeri, Cooper Bussberg, Joseph C. Cappelleri, Rebecca Germino, Lori Stockert, Caroline Vass, Adam M. Huber
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 21, Iss 1, Pp 1-15 (2023)
Abstract Background This study aimed to elicit and quantify preferences for treatments for juvenile idiopathic arthritis (JIA). Methods We conducted a discrete-choice experiment among adolescents with JIA in the United States (US) (n = 197) and Unite
Externí odkaz:
https://doaj.org/article/6a68757e3c2e4d10a441d43b20910f6e
Autor:
Marco Boeri, Maral K. Skelsey, James A. Schiro, Susan E. Dozier, Robert Glinert, Martin M. Okun
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Background Non-immunosuppressed patients with a history of multiple non-melanoma skin cancers (NMSCs) taking oral nicotinamide supplementation experienced a 23% decrease in annual NMSC risk in a randomized clinical trial. Patient preferences for risk
Externí odkaz:
https://doaj.org/article/82a1b587a4f840378f65aa28f1172952
Autor:
Neehar D. Parikh, Allicia Girvan, Joshua Coulter, Jonathon Gable, Jiat Ling Poon, Sangmi Kim, Anindya Chatterjee, Marco Boeri
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background Historically, high hepatocellular carcinoma (HCC)–related mortality has been, in part, due to lack of effective therapies; however, several systemic therapies have been recently approved for HCC treatment, including regorafenib
Externí odkaz:
https://doaj.org/article/bcabd4c300ff44ab93be3c152ba30ee4
Autor:
Laurence Jones, Marco Boeri, Mike Christie, Isabelle Durance, Karl L. Evans, David Fletcher, Laura Harrison, Anna Jorgensen, Dario Masante, James McGinlay, David M. Paterson, Reto Schmucki, Chris Short, Natalie Small, Georgina Southon, Timothy Stojanovic, Ruth Waters
Publikováno v:
People and Nature, Vol 4, Iss 1, Pp 166-179 (2022)
Abstract Cultural ecosystem services (CES), a key aspect of nature's contributions to people, remain a challenge to incorporate into decision making. One contributing factor is the difficulty of defining and describing these, due partly to: ongoing p
Externí odkaz:
https://doaj.org/article/4d00e002b78b45bbbffb6bed3d07dc2e
Autor:
Alan J. McMichael, Joseph P. M. Kane, Jonathan J. Rolison, Francis A. O'Neill, Marco Boeri, Frank Kee
Publikováno v:
BJPsych Open, Vol 8 (2022)
Background Public support for the implementation of personalised medicine policies (PMPs) within routine care is important owing to the high financial costs involved and the potential for redirection of resources from other services. Aims We aimed t
Externí odkaz:
https://doaj.org/article/e116a561d1454bcb81e2d59701460177